ISRN Preventive Medicine最新文献_第3页

Effect of green tea mouthwash on oral malodor. 绿茶漱口水对口腔异味的影响。

ISRN Preventive Medicine Pub Date : 2012-12-02 eCollection Date: 2013-01-01 DOI: 10.5402/2013/975148

Supanee Rassameemasmaung, Pakkarada Phusudsawang, Vanida Sangalungkarn

{"title":"Effect of green tea mouthwash on oral malodor.","authors":"Supanee Rassameemasmaung, Pakkarada Phusudsawang, Vanida Sangalungkarn","doi":"10.5402/2013/975148","DOIUrl":"https://doi.org/10.5402/2013/975148","url":null,"abstract":"This study aimed to determine the effect of green tea mouthwash on oral malodor, plaque, and gingival inflammation. Gingivitis subjects who had over 80 parts per billion of volatile sulfur compounds (VSC) in the morning breath were randomly assigned into green tea or placebo mouthwash group. At baseline, VSC, Plaque Index (PI) and Papillary Bleeding Index (PBI) were recorded. Participants were rinsed with the assigned mouthwash, and VSC level was remeasured at 30 minutes and 3 hours postrinsing. For the following 4 weeks, participants were asked to rinse with the assigned mouthwash twice daily. VSC, PI and PBI were remeasured at day 28. It was found that, at 30 minutes and 3 hours postrinsing, VSC was reduced by 36.76% and 33.18% in the green tea group and 19.83% and 9.17% in the placebo group, respectively. At day 28, VSC was reduced by 38.61% in the green tea group and 10.86% in the placebo group. VSC level in the green tea group was significantly different when compared to the placebo. PI and PBI were significantly reduced in both groups. However, no significant difference was found between groups. In conclusion, green tea mouthwash could significantly reduce VSC level in gingivitis subjects after rinsing for 4 weeks. ","PeriodicalId":14536,"journal":{"name":"ISRN Preventive Medicine","volume":"2013 ","pages":"975148"},"PeriodicalIF":0.0,"publicationDate":"2012-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062838/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32464626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 33

Candida infections and their prevention. 念珠菌感染及其预防。

ISRN Preventive Medicine Pub Date : 2012-11-04 eCollection Date: 2013-01-01 DOI: 10.5402/2013/763628

M Anaul Kabir, Zulfiqar Ahmad

{"title":"Candida infections and their prevention.","authors":"M Anaul Kabir, Zulfiqar Ahmad","doi":"10.5402/2013/763628","DOIUrl":"https://doi.org/10.5402/2013/763628","url":null,"abstract":"Infections caused by Candida species have been increased dramatically worldwide due to the increase in immunocompromised patients. For the prevention and cure of candidiasis, several strategies have been adopted at clinical level. Candida infected patients are commonly treated with a variety of antifungal drugs such as fluconazole, amphotericin B, nystatin, and flucytosine. Moreover, early detection and speciation of the fungal agents will play a crucial role for administering appropriate drugs for antifungal therapy. Many modern technologies like MALDI-TOF-MS, real-time PCR, and DNA microarray are being applied for accurate and fast detection of the strains. However, during prolonged use of these drugs, many fungal pathogens become resistant and antifungal therapy suffers. In this regard, combination of two or more antifungal drugs is thought to be an alternative to counter the rising drug resistance. Also, many inhibitors of efflux pumps have been designed and tested in different models to effectively treat candidiasis. However, most of the synthetic drugs have side effects and biomedicines like antibodies and polysaccharide-peptide conjugates could be better alternatives and safe options to prevent and cure the diseases. Furthermore, availability of genome sequences of Candida albicans and other non-albicans strains has made it feasible to analyze the genes for their roles in adherence, penetration, and establishment of diseases. Understanding the biology of Candida species by applying different modern and advanced technology will definitely help us in preventing and curing the diseases caused by fungal pathogens. ","PeriodicalId":14536,"journal":{"name":"ISRN Preventive Medicine","volume":"2013 ","pages":"763628"},"PeriodicalIF":0.0,"publicationDate":"2012-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2013/763628","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32464627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 46

Development of a Composite Lifestyle Index and Its Relationship to Quality of Life Improvement: The CLI Pilot Study. 复合生活方式指数的发展及其与生活质量改善的关系:CLI试点研究。

ISRN Preventive Medicine Pub Date : 2012-11-04 eCollection Date: 2013-01-01 DOI: 10.5402/2013/481030

Thomas L Lenz, Nicole D Gillespie, Jessica J Skradski, Laura K Viereck, Kathleen A Packard, Michael S Monaghan

{"title":"Development of a Composite Lifestyle Index and Its Relationship to Quality of Life Improvement: The CLI Pilot Study.","authors":"Thomas L Lenz, Nicole D Gillespie, Jessica J Skradski, Laura K Viereck, Kathleen A Packard, Michael S Monaghan","doi":"10.5402/2013/481030","DOIUrl":"https://doi.org/10.5402/2013/481030","url":null,"abstract":"An important component to optimal health is quality of life (QOL). Several healthy lifestyle behaviors have independently shown to improve QOL. The simultaneous implementation of multiple lifestyle behaviors is thought to be difficult, and the current literature lacks the assessment of multiple lifestyle behaviors simultaneously with respect to the effect on QOL. This current pilot study sought to develop a method to quantify multiple lifestyle behaviors into a single index value. This value was then measured with QOL for a possible correlation. The results showed that it is possible to convert multiple raw healthy lifestyle data points into a composite value and that an improvement in this value correlates to an improved QOL. After 12 months of participation in a cardiovascular risk reduction program, study participants (N = 35) demonstrated a 37.4% (P < 0.001) improvement in the composite lifestyle index (CLI). The improved CLI demonstrated a correlation with a statistically significant improvement in how participants rated their overall health in 12 months (r = 0.701, P < 0.001) as well as the number of self-reported unhealthy days per month in 12 months (r = -0.480, P = 0.004). ","PeriodicalId":14536,"journal":{"name":"ISRN Preventive Medicine","volume":"2013 ","pages":"481030"},"PeriodicalIF":0.0,"publicationDate":"2012-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062884/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32458221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 14

Indoor Tanning within UK Young Adults: An Extended Theory of Planned Behaviour Approach. 英国年轻人的室内晒黑:计划行为方法的扩展理论。

ISRN Preventive Medicine Pub Date : 2012-09-17 eCollection Date: 2013-01-01 DOI: 10.5402/2013/394613

Lorna J Dodd, Mark J Forshaw, Stella Williams

引用次数: 6

The Efficacy of Vectron 20 WP, Etofenprox, for Indoor Residual Spraying in Areas of High Vector Resistance to Pyrethroids and Organochlorines in Zambia. 在赞比亚拟除虫菊酯类杀虫剂和有机氯高抗药性地区室内残留喷洒Vectron 20 WP、乙托苯丙酯的效果

ISRN Preventive Medicine Pub Date : 2012-09-05 eCollection Date: 2013-01-01 DOI: 10.5402/2013/371934

Emmanuel Chanda, Alister Kandyata, Javan Chanda, Faustina N Phiri, Lucy Muzia, Mulakwa Kamuliwo

{"title":"The Efficacy of Vectron 20 WP, Etofenprox, for Indoor Residual Spraying in Areas of High Vector Resistance to Pyrethroids and Organochlorines in Zambia.","authors":"Emmanuel Chanda, Alister Kandyata, Javan Chanda, Faustina N Phiri, Lucy Muzia, Mulakwa Kamuliwo","doi":"10.5402/2013/371934","DOIUrl":"https://doi.org/10.5402/2013/371934","url":null,"abstract":"The selection of insecticide resistance in malaria vectors has the potential to compromise any insecticide-based vector control programme. To ensure that the insecticides used for indoor residual spraying and insecticide-treated nets in Zambia remain effective and their choice is evidence based, insecticide resistance surveillance and monitoring are essential. This study assessed and compared the residual efficacy of etofenprox (Vectron 20 WP), an ether pyrethroid, at 0.1 g/m(2) with pyrethroids: bifenthrin (Bistar 10 WP) and lambda-cyhalothrin (Icon 10 CS) at 25 mg/m(2) for indoor residual spraying. We also assessed the resistance status of etofenprox to local malaria vectors, An. funestus s.s and An. gambiae s.s, using World Health Organization standard protocols. The residual efficacy of Vectron 20 WP on cement, rendered walls of houses lasted for four months with 100% mortality. By the eighth month, the killing effect had reduced to 73.8% compared to 63.3% for bifenthrin and 77.0% for lambda-cyhalothrin. Susceptibility tests using standard World Health Organization assays on An. gambiae s.s showed susceptibility to etofenprox (0.1%) but some resistance was detected to Anopheles funestus s.s. The product is recommended as an ideal insecticide for indoor residual spraying for malaria control in Zambia as part of a resistance management programme in selected areas of the country. ","PeriodicalId":14536,"journal":{"name":"ISRN Preventive Medicine","volume":"2013 ","pages":"371934"},"PeriodicalIF":0.0,"publicationDate":"2012-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062862/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32456261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 8

Incomplete Early Childhood Immunization Series and Missing Fourth DTaP Immunizations; Missed Opportunities or Missed Visits? 幼儿免疫接种系列不完整和第四次 DTaP 疫苗接种缺失；错过机会还是错过就诊？

ISRN Preventive Medicine Pub Date : 2012-08-14 eCollection Date: 2013-01-01 DOI: 10.5402/2013/351540

Steve G Robison

{"title":"Incomplete Early Childhood Immunization Series and Missing Fourth DTaP Immunizations; Missed Opportunities or Missed Visits?","authors":"Steve G Robison","doi":"10.5402/2013/351540","DOIUrl":"10.5402/2013/351540","url":null,"abstract":"The successful completion of early childhood immunizations is a proxy for overall quality of early care. Immunization statuses are usually assessed by up-to-date (UTD) rates covering combined series of different immunizations. However, series UTD rates often only bear on which single immunization is missing, rather than the success of all immunizations. In the US, most series UTD rates are limited by missing fourth DTaP-containing immunizations (diphtheria/tetanus/pertussis) due at 15 to 18 months of age. Missing 4th DTaP immunizations are associated either with a lack of visits at 15 to 18 months of age, or to visits without immunizations. Typical immunization data however cannot distinguish between these two reasons. This study compared immunization records from the Oregon ALERT IIS with medical encounter records for two-year olds in the Oregon Health Plan. Among those with 3 valid DTaPs by 9 months of age, 31.6% failed to receive a timely 4th DTaP; of those without a 4th DTaP, 42.1% did not have any provider visits from 15 through 18 months of age, while 57.9% had at least one provider visit. Those with a 4th DTaP averaged 2.45 encounters, while those with encounters but without 4th DTaPs averaged 2.23 encounters. ","PeriodicalId":14536,"journal":{"name":"ISRN Preventive Medicine","volume":"2013 ","pages":"351540"},"PeriodicalIF":0.0,"publicationDate":"2012-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062864/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32456259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0